We are a complete service provider of cutting-edge technologies dedicated to the study of proteins & small molecule interactions.
We have over 130 cDNA libraries available in 35+ species and we can build a library from your material.
We also provide VHH antibody selection & validation services through the screening of a unique VHH synthetic library.
Hybrigenics wants to open a new pathway towards the fight against cancer. Established in 1997, the drug discovery company zeroes in on new drug targets and therapeutic biological components with the help of its computer programs involving protein sequencing and other high tech chemical screening techniques. What separates it from other drug researching companies is its Laboratory Information Management System (LIMS), a product that commercializes its library screening and navigating capabilities regarding DNA and other related biological sequencing. With its headquarters in Paris, Hybrigenics also owns Semaia BV, a subsidiary located in the Netherlands, and an additional office in the US.